Chronic Hepatitis B Infection: New Approaches towards Cure.
Ogunnaike M, Das S, Raut SS, Sultana A, Nayan MU, Ganesan M, Edagwa BJ, Osna NA, Poluektova LY.
Biomolecules. 2023 Aug 1;13(8):1208. doi: 10.3390/biom13081208.
Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity.
Zheng P, Dou Y, Wang Q.
Front Cell Infect Microbiol. 2023 Jun 22;13:1206720. doi: 10.3389/fcimb.2023.1206720. eCollection 2023.
[Chronic hepatitis B virus infection-related osteoporosis].
Zhang JY, Tang YM.
Zhonghua Gan Zang Bing Za Zhi. 2023 Jul 20;31(7):760-764. doi: 10.3760/cma.j.cn501113-20221204-00642.
Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy.
Zhao Q, Liu H, Tang L, Wang F, Tolufashe G, Chang J, Guo JT.
Antiviral Res. 2024 Jan;221:105782. doi: 10.1016/j.antiviral.2023.105782. Epub 2023 Dec 17.
Chronic hepatitis B in 2025: diagnosis, treatment and future directions.
Watson AG, Mulay AS, Gill US.
Clin Med (Lond). 2025 Nov;25(6):100527. doi: 10.1016/j.clinme.2025.100527. Epub 2025 Nov 4.
Immune therapies against chronic hepatitis B.
Akbar SMF, Yoshida O, Hiasa Y.
J Gastroenterol. 2022 Aug;57(8):517-528. doi: 10.1007/s00535-022-01890-8. Epub 2022 Jun 16.
Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?
Zhang J, Lin S, Jiang D, Li M, Chen Y, Li J, Fan J.
Liver Int. 2020 Mar;40(3):496-508. doi: 10.1111/liv.14369. Epub 2020 Jan 13.
Novel therapeutic strategies for chronic hepatitis B.
Phillips S, Jagatia R, Chokshi S.
Virulence. 2022 Dec;13(1):1111-1132. doi: 10.1080/21505594.2022.2093444.
Management of Chronic Hepatitis B in HIV-Coinfected Patients.
Fasano M, Poliseno MC, Fiore JR, Lo Caputo S, D'Arminio Monforte A, Santantonio TA.
Viruses. 2022 Sep 13;14(9):2022. doi: 10.3390/v14092022.
HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History.
Bonino F, Colombatto P, Brunetto MR.
Viruses. 2022 Jul 30;14(8):1691. doi: 10.3390/v14081691.
